🦁
|
Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms
A. Barlow,
M. Nicholson,
T. Herbert
|
7 |
2013 |
7 🦁
|
🐜
|
Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants
7 auth.
S. Hosgood,
S. Hosgood,
A. Barlow,
A. Barlow,
J. Hunter,
M. Nicholson,
...
M. Nicholson
|
6 |
2015 |
6 🐜
|
🐜
|
Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants
7 auth.
S. Hosgood,
S. Hosgood,
A. Barlow,
A. Barlow,
J. Hunter,
M. Nicholson,
...
M. Nicholson
|
6 |
2015 |
6 🐜
|
🦁
|
Case‐matched comparison of long‐term results of non‐heart beating and heart‐beating donor renal transplants
A. Barlow,
M. Metcalfe,
Y. Johari,
R. Elwell,
P. Veitch,
M. L. Nicholson
|
6 |
2009 |
6 🦁
|
🦁
|
Autophagy in diabetes: β-cell dysfunction, insulin resistance, and complications.
A. Barlow,
D. Thomas
|
6 |
2015 |
6 🦁
|
🐬
|
A pilot study assessing the feasibility of a short period of normothermic preservation in an experimental model of non heart beating donor kidneys.
S. Hosgood,
A. Barlow,
P. Yates,
M. Snoeijs,
E. van Heurn,
M. Nicholson
|
6 |
2011 |
6 🐬
|
🦁
|
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)
7 auth.
A. Barlow,
Jianling Xie,
C. E. Moore,
S. C. Campbell,
J. Shaw,
M. Nicholson,
...
T. Herbert
|
6 |
2012 |
6 🦁
|
🦁
|
Use of Ex Vivo Normothermic Perfusion for Quality Assessment of Discarded Human Donor Pancreases
13 auth.
A. Barlow,
M. Hamed,
D. Mallon,
Rebecca Brais,
Fiona M. Gribble,
MA Scott,
WJ Howat,
J. Bradley,
E. Bolton,
G. Pettigrew,
...
S. Hosgood,
M. L. Nicholson,
K. Saeb‐Parsy
|
6 |
2015 |
6 🦁
|
🐜
|
The use of ex-vivo normothermic perfusion for the resuscitation and assessment of human kidneys discarded because of inadequate in situ perfusion
7 auth.
S. Hosgood,
S. Hosgood,
A. Barlow,
A. Barlow,
J. Dormer,
M. Nicholson,
...
M. Nicholson
|
5 |
2015 |
5 🐜
|